logo
Plus   Neg
Share
Email

Google Introduces Addiction And Recovery Resources

addictionrecovery sept13 lt

Google has launched a new website called 'Recover Together,' a resource intended to help people recover from addiction or substance use disorder.

The new service was launched by the search giant in recognition of the National Recovery Month in September. Google noted that more than 23 million Americans are recovering from addiction, while 20 million are still struggling to seek treatment.

The new website is part of Google's ongoing efforts to combat the opioid crisis. The company said that in August, it saw an "all-time high" in search interest for things like "rehab near me," "addiction treatment near me" and "how to help an addict."

Every September, the U.S. Department of Health & Human Services sponsors Recovery Month to increase awareness and understanding of mental and substance use disorders and celebrate the people who recover.

Google said it is launching two new Google Maps locator tools that will connect people with crucial recovery resources, including a Recovery Locator Tool and Naloxone Locator Tool. The company is partnering with Recovery Resource hub to fill out maps.

The Recovery Locator Tool is a map with locations of more than 83,000 recovery support meetings and other services such as school-based and family support. These meetings take place at more than 33,000 community centers, churches, and other spaces.

The Naloxone Locator Tool can be used to locate pharmacies that offer Naloxone, a non-prescription drug that can be used to treat opioid overdoses in an emergency situation. It already includes 20,000 pharmacies, including CVS, Rite-Aid and Walgreens, in 50 states.

In addition to these new tools, the site points to other resources for those seeking treatment, including a self-assessment screener from the National Institute of Drug Abuse and state-specific Helpline resources and hotlines.

Earlier this year, Google Maps began listing drug disposal locations on Google Maps where people can safely discard unneeded medications and help prevent drug misuse.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Novacyt S.A. said it is seeing unprecedented demand for the novel coronavirus or COVID-19 diagnostic test kit developed by Primerdesign, the company's molecular diagnostics division based in the UK. As of March 27, Primerdesign has sold and received orders for more than 17.8 million pounds of its CE-Mark COVID-19 tests. Novacyt is currently selling its COVID-19 test to more than 80 countries. The U.S. Food and Drug Administration has issued an Emergency Use Authorization to allow anti-malaria drugs hydroxychloroquine sulfate and chloroquine phosphate donated to the Strategic National Stockpile as possible treatments for coronavirus (COVID-19) patients. This is the first EUA for a drug related to the COVID-19 response. Gilead Sciences Inc. said it is transitioning to "expanded access programs" from "compassionate use" programs for its experimental anti-coronavirus drug, remdesivir. The company noted that the expanded access will allow hospitals or physicians to apply for emergency use of remdesivir for multiple severely ill patients at one time, as they struggle to deal with the COVID-19 or coronavirus pandemic.
Follow RTT
>